[1. Emery A, Muntoni F. Duchenne muscular dystrophy. 3rd ed. New York, NY: Oxford University Press, 2003.]Search in Google Scholar
[2. Cotton S, Voudouris NJ, Greenwood KM. Intelligence and Duchenne muscular dystrophy: Full-scale, verbal, and performance intelligence quotients. Dev Med Child Neurol. 2001; 43(7): 497-501.10.1017/S0012162201000913]Search in Google Scholar
[3. Cotton S, Voudouris N, Douglas J. Key findings from a meta-analytical study on intellectual functions in Duchenne muscular dystrophy. J Intell Disabil Res. 2000; 44(3-4): 248-248.]Search in Google Scholar
[4. Koenig M, Hoffman EP, Bertelson CJ, Monaco AP, Feener C, Kunkel LM. Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell. 1987; 50(3): 509-517.10.1016/0092-8674(87)90504-6]Search in Google Scholar
[5. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics. 1988; 2(1): 90-95.10.1016/0888-7543(88)90113-9]Search in Google Scholar
[6. Lidov HG, Byers TJ, Watkins SC, Kunkel LM. Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons. Nature. 1990; 348(6303): 725-728.10.1038/348725a02259381]Search in Google Scholar
[7. Tokarz SA, Duncan NM, Rash SM, Sadeghi A, Dewan AK, Pillers DA. Redefinition of dystrophin isoform distribution in mouse tissue by RTPCR implies role in nonmuscle manifestations of duchenne muscular dystrophy. Mol Genet Metab. 1998; 65(4): 272-281.10.1006/mgme.1998.27639889014]Search in Google Scholar
[8. Anderson JL, Head SI, Rae C, Morley JW. Brain function in Duchenne muscular dystrophy. Brain. 2002; 125(1): 4-13.10.1093/brain/awf01211834588]Search in Google Scholar
[9. Perronnet C, Vaillend C. Dystrophins, utrophins, and associated scaffolding complexes: Role in mammalian brain and implications for therapeutic strategies. J Biomed Biotechnol. 2010; 2010: 849426. doi: 10.1155/2010/ 849426.]Search in Google Scholar
[10. Pillers DA, Bulman DE, Weleber RG, Sigesmund DA, Musarella MA, Powell BR, et al. Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nat Genet. 1993; 4(1): 82-86.10.1038/ng0593-828513332]Search in Google Scholar
[11. Lidov HG, Selig S, Kunkel LM. Dp140: A novel 140 kDa CNS transcript from the dystrophin locus. Hum Mol Genet. 1995; 4(3): 329-335.10.1093/hmg/4.3.3297795584]Search in Google Scholar
[12. Byers TJ, Lidov HG, Kunkel LM. An alternative dystrophin transcript specific to peripheral nerve. Nat Genet. 1993; 4(1): 77-81.10.1038/ng0593-778513330]Search in Google Scholar
[13. Bar S, Barnea E, Levy Z, Neuman S, Yaffe D, Nudel U. A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem J. 1990; 272(2): 557-560.10.1042/bj272055711497402176467]Search in Google Scholar
[14. Taylor PJ, Betts GA, Maroulis S, Gilissen C, Pedersen RL, Mowat DR, et al. Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS One. 2010; 5(1): e8803. doi: 10.1371/ journal.pone.0008803.10.1371/journal.pone.0008803]Search in Google Scholar
[15. Daoud F, Angeard N, Demerre B, Martie I, Benyaou R, Leturcq F, et al. Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression. Hum Mol Genet. 2009; 18(20): 3779-3794.10.1093/hmg/ddp320]Search in Google Scholar
[16. Tozawa T, Itoh K, Yaoi T, Tando S, Umekage M, Dai H, et al. The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brain. Mol Neu-robiol. 2012; 45(2): 287-297.10.1007/s12035-012-8233-5]Search in Google Scholar
[17. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligationdependent probe amplification. Nucleic Acids Res. 2002; 30(12): e57. doi: 10.1093/nar/gnf056.10.1093/nar/gnf056]Search in Google Scholar
[18. Chamberlain JS, Gibbs RA, Ranier JE, Nguyen PN, Caskey CT. Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res. 1988; 16(23): 11141-11156.10.1093/nar/16.23.11141]Search in Google Scholar
[19. Beggs AH, Koenig M, Boyce FM, Kunkel LM.Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet. 1990; 86(1): 45-48.10.1007/BF00205170]Search in Google Scholar
[20. Kunkel LM, Snyder JR, Beggs AH, Boyce FM, Feener CA. Searching for dystrophin gene deletions in patients with atypical presentations. In: Lindsten J, Petterson U, Eds. Etiology of Human Diseases at the DNA Level. New York, NY: Raven Press. 1991: 51-61.]Search in Google Scholar
[21. Den Dunnen JT, Antonarakis SE. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat. 2000; 15(1): 7-12.10.1002/(SICI)1098-1004(200001)15:1<7::AID-HUMU4>3.0.CO;2-N]Search in Google Scholar
[22. Bushby KM, Appleton R, Anderson LV, Welch JL, Kelly P, Gardner-Medwin D. Deletion status and intellectual impairment in Duchenne muscular dystrophy. Dev Med Child Neurol. 1995; 37(3): 260-269.10.1111/j.1469-8749.1995.tb12000.x]Search in Google Scholar
[23. Desguerre I, Christov C, Mayer M, Zeller R, Becane HM, Bastuji-Garin S, et al. Clinical heterogeneity of Duchenne Muscular Dystrophy (DMD): Definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS One. 2009; 4(2): e4347. doi: 10.1371/ ournal.pone.0004347. 10.1371/journal.pone.0004347]Search in Google Scholar
[24. Wechsler D. Manual for the Wechsler Intelligence Scale for Children, 3rd ed. New York, NY: Psychological Corporation, 1991.]Search in Google Scholar
[25. Brunet O, Lezine PUF. Le Developpement Psychologique del al Premiere Enfance. Issy-les- Moulineaux. France: Editions Scientifiques et Psychotechniques, 1951.]Search in Google Scholar
[26. Doll EA. Vineland Social Maturity Scale. Oxford, UK: Educational Test Bureau, 1947.]Search in Google Scholar
[27. Hinton VJ, Fee RJ, Goldstein EM, De Vivo DC. Verbal and memory skills in males with Duchenne muscular dystrophy. Dev Med Child Neurol. 2007; 49(2): 123-128.10.1111/j.1469-8749.2007.00123.x]Search in Google Scholar
[28. D’Angelo MG, Lorusso ML, Civati F, Comi GP, Magri F, Del Bo R, et al. Neurocognitive profiles in Duchenne muscular dystrophy and gene mutation site. Pediatr Neurol. 2011; 45(5): 292-299.10.1016/j.pediatrneurol.2011.08.003]Search in Google Scholar
[29. Wingeier K, Giger E, Strozzi S, Kreis R, Joncourt F, Conrad B, et al. Neuropsychological impairments and the impact of dystrophin mutations on general cognitive functioning of patients with Duchenne muscular dystrophy. J Clin Neurosci. 2011; 18(1): 90-95.10.1016/j.jocn.2010.07.118]Search in Google Scholar
[30. Lorusso ML, Civati F, Molteni M, Turconi AC, Bresolin N, D’Angelo MG. Specific profiles of neurocognitive and reading functions in a sample of 42 Italian boys with Duchenne Muscular Dystrophy. Child Neuropsychol. 2013; 19(4): 350-369.10.1080/09297049.2012.660912]Search in Google Scholar
[31. Chamova T, Guergueltcheva V, Raycheva M, Todorov T, Genova F, Bichev S, et al. Association between loss of Dp140 and cognitive impairment in Du-henne and Becker dystrophies. Balkan J Med Genet. 2013; 16(1): 21-30.10.2478/bjmg-2013-0014]Search in Google Scholar
[32. Knuesel I, Bornhauser BC, Zuellig RA, Heller F, Schaub MC, Fritschy JM. Differential expression of utrophin and dystrophin in CNS neurons: An in situ hybridization and immunohistochemical study. J Comp Neurol. 2000; 422(4): 594-611.10.1002/1096-9861(20000710)422:4<594::AID-CNE8>3.0.CO;2-Q]Search in Google Scholar
[33. Sekiguchi M, Zushida K, Yoshida M, Maekawa M, Kamichi S, Yoshida M, et al. A deficit of brain dystrophin impairs specific amygdala GABAergic transmission and enhances defensive behaviour in mice. Brain. 2009; 132(1): 124-135.10.1093/brain/awn253]Search in Google Scholar
[34. Moizard MP, Toutain A, Fournier D, Berret F, Raynaud M, Billard C, et al. Severe cognitive impairment in DMD: Obvious clinical indication for Dp71 isoform point mutation screening. Eur J Hum Genet. 2000; 8(7): 552-556.10.1038/sj.ejhg.5200488]Search in Google Scholar
[35. Moizard MP, Billard C, Toutain A, Berret F, Marmin N, Moraine C. Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy? Am J Med Genet. 1998; 80(1): 32-41.10.1002/(SICI)1096-8628(19981102)80:1<32::AID-AJMG6>3.0.CO;2-Y]Search in Google Scholar
[36. Chelly J, Khelfaoui M, Francis F, Cherif B, Bienvenu T. Genetics and pathophysiology of mental retardation. Eur J Hum Genet. 2006; 14(6): 701-713.10.1038/sj.ejhg.5201595]Search in Google Scholar
[37. Felisari G, Martinelli Boneschi F, Bardoni A, Sironi M, Comi GP, Robotti M, et al. Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology. 2000; 55(4): 559-564.10.1212/WNL.55.4.559]Search in Google Scholar
[38. Haenggi T, Soontornmalai A, Schaub MC, Fritschy JM. The role of utrophin and Dp71 for assembly of different dystrophin-associated protein complexes (DPCs) in the choroid plexus and microvasculature of the brain. Neuroscience. 2004; 129(2): 403-413.10.1016/j.neuroscience.2004.06.07915501597]Search in Google Scholar
[39. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP. Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J Biol Chem. 1995; 270(45): 27305-27310.10.1074/jbc.270.45.273057592992]Search in Google Scholar
[40. Sigelman C, Rider EA. Life-Span Human Development, 7th ed. Belmont, CA: Wadsworth Cengage Learning, 2012.]Search in Google Scholar
[41. Wu JY, Kuban KC, Allred E, Shapiro F, Darras BT. Association of Duchenne muscular dystrophy with autism spectrum disorder. J Child Neurol. 2005; 20(10): 790-795.10.1177/0883073805020010020116417872]Search in Google Scholar
[42. Ferlini A, Neri M, Gualandi F. The medical genetics of dystrophinopathies: Molecular genetic diagnosis and its impact on clinical practice. Neuromusc Disord. 2013; 23(1): 4-14. 10.1016/j.nmd.2012.09.00223116935]Search in Google Scholar